Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome

Archives of Internal Medicine

Volumn 161, Issue 20, 2001, Pages 2447-2454

  Loeys, B ^a   Nuytinck, L ^a   Delvaux, I ^a   De Bie, S ^a   De Paepe, A ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRILLIN;

ADULT; AGE; AORTA DISSECTION; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE SEVERITY; ECTOPIA LENTIS; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MARFAN SYNDROME; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL;

EID: 0035851312     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.20.2447     Document Type: Article

References (38)

1. Marian syndrome and other disorders of fibrillin
2. Marian syndrome caused by a recurrent de novo missense mutation in the fibrillin gene
3. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders
4. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome
5. Replacement of the aortic root in patients with Marfan's syndrome
6. International nosology of heritable disorders of connective tissue disorders of connective tissue, Berlin
7. A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome
8. Revised diagnostic criteria for the Marfan syndrome
9. Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome
10. An extra cysteine in one of the non-calcium-binding epidermal growth factor-like motifs of the FBN1 polypeptide is connected to a novel variant of Marfan syndrome
11. Fibrillin-1 mutations in Marfan syndrome and other type-1 fibrillinopathies
12. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome
13. A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection
14. Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms
15. Cardiovascular abnormalities in relatives of patients operated on for annulo-aortic ectasia: A clinical and echocardiographic study on 40 families
16. Familial aortic dissecting aneurysms
17. Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosome 15 and 5
18. Confirmation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: Evidence for solvent-induced bends in DNA heteroduplexes
19. Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: Comparison with denaturing gradient gel electrophoresis and nucleotide sequencing
20. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms
21. Glycine to tryptophan substitution in type I collagen in a patient with OI type III: A unique collagen mutation
22. Comparison of conformationsensitive gel electrophoresis and single-strand conformation polymorphism analysis for detection of mutations in the BRCA1 gene using optimized conformation analysis protocols
23. Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformationsensitive gel electrophoresis for mutation detection in TSC2
24. Mutation screening of all 65 exons of the fibrillin-1 gene in 60 patients with Marfan syndrome: Report of 12 novel mutations
25. Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons
26. Fibrillin (FBN1) mutations in the "neonatal region": Toward genotype/phenotype correlation in neonatal Marfan syndrome
27. Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibril assembly and cause severe Marfan syndrome
28. Denaturing HPLC-identified novel FBN1 mutations, polymorphisms, and sequence variants in Marfan syndrome and related connective tissue disorders
29. Correlation of a recurrent FBN1 mutation (R122C) with an atypical familial Marfan syndrome phenotype
30. Molecular analysis of eight mutations in FBN1
31. Novel exon skipping mutation in the fibrillin-1 gene: Two "hot spots" for the neonatal Marfan syndrome
32. Characterisation of four novel fibrillin-1 (FBN1) mutations in Marfan syndrome
33. Demonstration of the recurrence of Marfan-like skeletal and cardiovascular manifestations due to germline mosaicism for an FBN1 mutation
34. Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: Distinct effects on biochemical and clinical phenotypes
35. Four novel FBN1 mutations: Significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome
36. Multiple molecular mechanisms underlying subdiagnostic variants of Marfan syndrome
37. DHPLC, SSCP, A comparison of BRCA1 mutation analysis by direct sequencing
38. Where is the Marfan mutation? sensitivity study of denaturing HPLC (DHPLC) for routine mutation detection in the Marfan syndrome